Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies

IMPRESS (Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) I and II examined the clinical efficacy and safety of collagenase Clostridium histolyticum intralesional injections in subjects with Peyronie disease. Co-primary outcomes in these identical phase 3 randomized,...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Journal of urology Ročník 190; číslo 1; s. 199
Hlavní autoři:	Gelbard, Martin, Goldstein, Irwin, Hellstrom, Wayne J G, McMahon, Chris G, Smith, Ted, Tursi, James, Jones, Nigel, Kaufman, Gregory J, Carson, 3rd, Culley C
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.07.2013
Témata:	Adult Clinical Trials, Phase III as Topic Clostridium histolyticum - enzymology Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Follow-Up Studies Humans Injections, Intralesional Male Maximum Tolerated Dose Microbial Collagenase - administration & dosage Middle Aged Patient Safety Patient Satisfaction Penile Induration - diagnosis Penile Induration - drug therapy Prospective Studies Randomized Controlled Trials as Topic Risk Assessment Severity of Illness Index Treatment Outcome
ISSN:	1527-3792, 1527-3792
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!